Lynn T. Tanoue, MD, MBA, Chair
Dr. Tanoue is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine. She is Professor of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at Yale School of Medicine in New Haven, Connecticut. She directs the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale-New Haven, codirects the Yale Thoracic Oncology Program, and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology.
Dr. Tanoue is currently chair of the American Thoracic Society Thoracic Oncology Assembly. She has served in leadership roles in the American College of Chest Physicians and the National Association for the Medical Direction of Respiratory Care. She serves on numerous committees at her home institutions, including as a member of the governing Board of Yale Medicine, and as immediate past-President of the medical staff of Yale New Haven Hospital. Dr. Tanoue is currently President of the Board of Directors of the Yale Medical Symphony Orchestra.
Dr. Tanoue received her bachelor’s degree from Harvard University and medical degree from Yale School of Medicine. She did her internal medicine residency, chief residency and fellowship in pulmonary/critical care medicine at Yale-New Haven Hospital. Dr. Tanoue received her master's in business administration from Yale School of Management.
As of May 2020, Dr. Tanoue reported the following external relationships:
Work as an author or editor for the following companies, with compensation as listed:
- UpToDate, receiving compensation for authorship.
- Elsevier, receiving compensation as an Editor of Year Book of Pulmonary Disease.
Dr. Tanoue serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:
- American Thoracic Society, Chair, Thoracic Oncology Assembly, receiving reimbursement for travel expenses.
John H. Hansen-Flaschen, MD
Dr. Hansen-Flaschen is the Paul F. Harron Family Emeritus Professor of Medicine at the University of Pennsylvania. He founded and served as the first director of the Paul Harron Lung Center and served as the Founding Editor-in-Chief of the Annals of the American Thoracic Society. Previously, Dr. Hansen-Flaschen served for 25 years as the Chief of the Pulmonary, Allergy and Critical Care Division of the Department of Medicine at Penn. He built the full-time clinical and research faculty of the division to 60 members. First as the Pulmonary Fellowship Training Program Director and then as Division Chief, he also oversaw the training of more than 180 pulmonary and critical care fellows between 1982 and 2014.
Dr. Hansen-Flaschen is board certified in both Internal Medicine and Pulmonary Disease. In addition to his administrative and editorial responsibilities, he practices consultative pulmonary medicine special focus on diagnostic dilemmas and second opinions. In 2017, Dr. Hansen-Flaschen founded, and he currently directs the Jay and Randy Fishman Program for Home Assisted Ventilation.
His scholarly interests focus on shared medical decision making near the end of life and on humanizing the experience of patients and family members in intensive care units. Dr. Hansen-Flaschen has published more than 100 articles and textbook chapters and has edited three books. He lectures and teaches nationally and internationally on management of advanced lung diseases near the end of life and related topics. He is a member of the American Board of Internal Medicine (ABIM) Pulmonary Disease Board and was previously a member of the ABIM Pulmonary Disease Board Exam Committee.
Dr. Hansen-Flaschen completed his bachelor's degree in chemistry with honors at Brown University and received his medical degree from New York University. He served as a resident and chief resident in medicine and then as a fellow in pulmonary and critical care medicine at the Hospital of the University of Pennsylvania.
As of May 2019, Dr. Hansen-Flaschen reported the following external relationships:
Dr. Hansen-Flaschen serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- American Thoracic Society Foundation, Member of Board of Trustees, without compensation.
Susan Murin, MD
Dr. Murin is currently Vice-Chair of Internal Medicine, Interim Associate Dean for Clinical Affairs and Co-Director of Ambulatory Operations at UC Davis Health System. Former roles at UC Davis include Program Director for the Pulmonary and Critical Care Fellowship, Chief of the Division of Pulmonary, Critical Care and Sleep Medicine, and Chief of the Medical Staff. Her past national service has included membership on the ACGME's Internal Medicine RRC, Chair of the Pulmonary Medicine Test-Writing Committee for the American Board of Internal medicine, and Chair of the Association of Pulmonary and Critical Care Medicine Program Directors. Dr. Murin currently serves as a member of the Internal Medicine Pulmonary Disease Board. She is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine.
Dr. Murin's research has been focused in two areas: epidemiology of venous thromboembolism and the effects of smoking on the natural history of breast cancer. She remains active in clinical care and teaching at both UC Davis and the Northern California VA. When not working she enjoys spending time with three children, Scuba diving and tennis.
Dr. Murin received her undergraduate degree from Rutgers University and her medical degree at New York University. She completed her residency in Internal Medicine at NYU-Bellevue and fellowship in Pulmonary and Critical Care Medicine at Yale University. She subsequently received an MSc in Clinical Epidemiology from the Harvard School of Public Health and an MBA from the UC Davis Graduate School of Management.
AS of May 2020, Dr. Murin reported no external relationships.
Kevin M. O'Neil, MD
Dr. O'Neil is board certified in Internal Medicine, Pulmonary Medicine, Critical Care and Sleep Medicine. He is in private practice and a partner at Wilmington Health, a multispecialty group in Wilmington, North Carolina.
He served in a variety of roles while on active duty including chief medical resident, Chair, Critical Care Medicine, Pulmonary Division Chief, Pulmonary & Critical Care fellowship Program Director, Navy specialty leader for Pulmonary/CCM and GME Director for the National Naval Medical Center.
Dr. O’Neil serves as a member of the American Board of Internal Medicine Pulmonary Disease Board. He is active in clinical practice guideline development with the American College of Chest Physicians and in respiratory care education through the Commission on Accreditation for Respiratory Care (CoARC).
Dr. O’Neil holds an undergraduate degree in chemical engineering from the University of Delaware, a medical degree from Jefferson Medical College in Philadelphia and a master's in healthcare administration from the University of North Carolina at Chapel Hill. He completed his residency and fellowship training at the Naval Hospital in Portsmouth, Virginia.
As of May 2020, Dr. O'Neil reported the following external relationships:
Dr. O’Neil serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American College of Chest Physicians, Chair, Guidelines Committee, Member of Programming Committee for Annual Meeting, receiving reimbursement for travel expenses.
- Committee on Accreditation for Respiratory Care, Commissioner and Executive Committee Member, serving as Treasurer, receiving reimbursement for travel expenses.
Peter H.S. Sporn, MD
Dr. Sporn is Professor of Medicine and Cell and Molecular Biology at the Feinberg School of Medicine of Northwestern University. He is Program Director of the Northwestern University Pulmonary and Critical Care Fellowship Program, a position he has held since 1996, and since which time he has directed the training of 75 pulmonary and critical fellows. He has been a member of the American Board of Internal Medicine Pulmonary Board Test-writing Committee since 2010.
Dr. Sporn’s clinical interests include asthma, chronic obstructive pulmonary disease, eosinophilic respiratory diseases, interstitial lung diseases and sarcoidosis. His research interests include the role of eicosanoids in lung inflammation, eosinophil biology, mechanosignaling in lung injury and repair, innate immunity and lung host defense. He has been supported by the National Institutes of Health and the Department of Veterans Affairs throughout his research career.
Dr. Sporn received his undergraduate degree from the University of Chicago and his medical degree from Wayne State University School of Medicine. He trained in internal medicine at Bronx Municipal Hospital Center/Albert Einstein College of Medicine and in Pulmonary and Critical Medicine at the University of Michigan.
As of May 2019, Dr. Sporn reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Northwestern University, from the following company:
Attendance at investigators’ meetings, with compensation for travel expenses from the following company:
Dr. Sporn serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Thoracic Society, Scientific Advisory Committee, receiving reimbursement for travel expenses.
- National Institutes of Health, Grant Reviewer, receiving reimbursement for travel expenses.
- Veterans Affairs, Grant Reviewer, receiving reimbursement for travel expenses.
Grant funding from not-for-profit healthcare-related organizations for project expenses, paid to Northwestern University, from the following organizations:
- American Thoracic Society
- National Institutes of Health
- Foundation for Sarcoidosis Research
Geneva Tatem, MD
Dr. Tatem is Associate Professor of Medicine at Wayne State University School of Medicine and the Program Director for the Pulmonary and Critical Care Medicine and multispecialty Critical Care Medicine fellowship programs at Henry Ford Hospital. She also serves as the Associate Division Head of Pulmonary and Critical Care Medicine.
Dr. Tatem served as chair of the graduate medical education committee, of which she remains an active member. She also chaired the medical education advocacy team focused on raising awareness of medical education funding needs in the Michigan State Legislature. Her academic interest is on process improvement as applied to medical education. She has guided each of her fellowship programs through curriculum innovations, most recently behavioral based interviews for fellowship recruitment. She was a physician lead for the education and training team in the Sepsis Project, a transformational system redesign process to improve the effectiveness of sepsis care throughout the 5 hospitals within Henry Ford Health System (HFHS) and earned a Focus on People award from the HFHS Board of Governors in recognition for her commitment to process improvement and patient safety throughout the health system.
Dr. Tatem is a Fellow of the American College of Chest Physicians and is actively involved in the Association of Pulmonary and Critical Care Medicine Program Directors, the Section of Medical Education of the American Thoracic Society, the Society of Critical Care Medicine, and the National Medical Association.
Dr. Tatem received a bachelor of science degree in chemical engineering at Cornell University and earned her medical degree from the University of Michigan School of Medicine. She completed her internship in Emergency Medicine at the University of Chicago and completed residency in internal medicine and fellowship in pulmonary and critical care Medicine at Henry Ford Hospital. She joined the faculty at Henry Ford Hospital in 2007.
As of January 2020, Dr. Tatem reported no external relationships.
Carol K. Yochum
Ms. Yochum had a career for over 35 years in management and as a Financial Analyst. Ms. Yochum currently serves as a member of the American Board of Internal Medicine Pulmonary Disease Board.
After several years of shortness of breath, wheezing and of lung infections she was finally diagnosed with Alpha 1 Antitrypsin Deficiency (A1AD or AATD,) a genetic disorder that may result in lung disease or liver disease. She was severely affected in her lungs and began augmentation therapy to slow down the progression of the disease. Since her lungs were very severely damaged and she was otherwise healthy it was suggested for her to have a bilateral lung transplant.
After being diagnosed with Alpha 1 and of need of a lung transplant, she had to move through this new reality and concentrate on learning about it and adapting to a new lifestyle. She became involved in several pulmonary and Alpha 1 online support groups, attended pulmonary rehabilitation and became an advocate in the Alpha 1 community.
In early 2015 she received her bilateral lung transplant; the first year she interacted with her transplant pulmonologists and all the clinicians nearly weekly. She found that her life as a lung transplant patient made her become mindful of everything. Throughout the past five years of her transplant life, there have been many challenges as it tests the limits of human strength and courage. It also requires commitment, faith as well as mental, emotional and physical endurance.
Ms. Yochum is originally from Minnesota and has lived in Colorado for most of her life. She has a bachelor's degree in business from Regis University.
As of August 2019, Ms. Yochum reported no ongoing external relationships.
Corinne R. Young, NP, FCCP
Ms. Young is a Nurse Practitioner (NP) who began working in pulmonary disease in California in 2005, and since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Ms. Young is currently one of the first 10 Advanced Practice Providers nationwide to become a Fellow of the American College of Chest Physicians.
Involvement and the representation of advanced practice providers in the pulmonary world has been one of her priorities, Ms. Young founded and is the President of the Association of Pulmonary Advanced Practice Providers (APAPP), a community for nurse practitioners and physician assistants working in pulmonary medicine. She also works closely with the American College of Chest Physicians’ CHEST programs and serves on the Interprofessional Team Network, Clinical Research Network. Additionally, Ms. Young is a member of the American Board of Internal Medicine Pulmonary Disease Board.
Ms. Young's education started as a bachelor's-prepared registered nurse working in critical care in medical, surgical, cardiac and trauma ICUs. She then pursued her master's degree in nursing at California State University, Bakersfield Family Practice Nurse Practitioner program and became board certified in Family Practice through the American Association of Nurse Practitioners.
As of August 2019, Ms. Young reported the following external relationships:
Funding for clinical trial expenses, paid to Colorado Springs Pulmonary Consultants, from the following companies:
- AstraZeneca, for an observational chronic obstructive pulmonary disease trial.
- GlaxoSmithKline, for a trial for treatment of chronic obstructive pulmonary disease exacerbations.
Service on a research-related expert panel or advisory board for the following company, without compensation:
- Genentech, serving on a nursing advisory board.
Ms. Young serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Association of Pulmonary Advanced Practice Providers, President and Founder, receiving reimbursement for travel expenses.